Prelude Capital Management, LLC Idera Pharmaceuticals, Inc. Transaction History
Prelude Capital Management, LLC
- $1.57 Billion
- Q3 2024
A detailed history of Prelude Capital Management, LLC transactions in Idera Pharmaceuticals, Inc. stock. As of the latest transaction made, Prelude Capital Management, LLC holds 20,200 shares of IDRA stock, worth $60,801. This represents 0.0% of its overall portfolio holdings.
Number of Shares
20,200Holding current value
$60,801% of portfolio
0.0%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding IDRA
# of Institutions
1Shares Held
0Call Options Held
0Put Options Held
0About IDERA PHARMACEUTICALS, INC.
- Ticker IDRA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 62,296,900
- Market Cap $188M
- Description
- Idera Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of drugs for rare disease indications in the United States. It offers Tilsotolimod (IMO-2125), a synthetic phosphorothioate oligonucleotide that acts as a direct agonist of TLR9 to stimulate the immune systems and for treating s...